about
Echocardiography screening for rheumatic heart disease in Ugandan schoolchildren.Echocardiographic pattern and severity of valve dysfunction in children with rheumatic heart disease seen at Uganda Heart Institute, Mulago hospital.Socioeconomic and environmental risk factors among rheumatic heart disease patients in Uganda.Resolution of dilated cardiomyopathy in an adolescent with change of a failing highly active antiretroviral drug therapyCharacteristics, complications, and gaps in evidence-based interventions in rheumatic heart disease: the Global Rheumatic Heart Disease Registry (the REMEDY study).Management of rheumatic heart disease in uganda: the emerging epidemic of non-AIDS comorbidity in resource-limited settings.Cardiac Conduction Safety during Coadministration of Artemether-Lumefantrine and Lopinavir/Ritonavir in HIV-Infected Ugandan Adults.The utility of handheld echocardiography for early rheumatic heart disease diagnosis: a field studyCardiovascular complications in newly diagnosed rheumatic heart disease patients at Mulago Hospital, Uganda.Handheld echocardiography versus auscultation for detection of rheumatic heart disease.Simplified rheumatic heart disease screening criteria for handheld echocardiography.A case of anomalous origin of the left coronary artery presenting with acute myocardial infarction and cardiovascular collapse.The utility of handheld echocardiography for early diagnosis of rheumatic heart disease.Latent rheumatic heart disease: outcomes 2 years after echocardiographic detection.Correction: Socioeconomic and Environmental Risk Factors among Rheumatic Heart Disease Patients in Uganda
P50
Q34277085-AF50E451-EA05-4C34-B001-42A0F4EFADE5Q34405729-391E0F8A-4EB2-42B1-9B0C-A87DE828B977Q34405841-15C0D3AF-69A8-4D12-9D4C-695B821BB295Q35207358-CEFF501D-1A61-4495-95EC-AF598913400BQ35450868-9147B901-8A72-4766-9437-51FF5AB052A9Q35580357-A4DFEE6B-6EC0-41A2-81C6-2784B0B448EAQ35692134-BD65EA22-7CFA-4DFC-95B9-AC6D084275A5Q35975040-C8C37C29-E494-429F-ADA0-619CFB43BBBDQ37042030-9A433D02-EAE9-43B6-8806-601275CB066FQ38859730-AA1D9EDF-D74F-46B1-A129-08D29F700503Q38860012-5BBA7B29-C23D-4D87-8B22-4D6E55400FA4Q38863100-02015921-FB2E-4915-B0C3-52435F27712EQ38864213-D4FA1661-C362-4D91-8922-1FD77D5A5720Q40207252-D5A7D827-02E2-44ED-BE58-B903273D6AAEQ59289825-8F94D16C-6683-4851-B210-73AA5B87DED6
P50
description
researcher ORCID ID = 0000-0002-2895-3626
@en
wetenschapper
@nl
name
Peter Lwabi
@ast
Peter Lwabi
@en
Peter Lwabi
@es
Peter Lwabi
@nl
type
label
Peter Lwabi
@ast
Peter Lwabi
@en
Peter Lwabi
@es
Peter Lwabi
@nl
prefLabel
Peter Lwabi
@ast
Peter Lwabi
@en
Peter Lwabi
@es
Peter Lwabi
@nl
P106
P31
P496
0000-0002-2895-3626